Patents by Inventor Shannon E. Mullican

Shannon E. Mullican has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Nor-1 and nur77 nuclear receptors as targets for anti-leukemia therapy
    Publication number: 20030220288
    Abstract: The present invention is directed to the application of nuclear receptor transcription factors as molecular targets for therapeutic intervention in the treatment of myeloid leukemia. More specifically, nor-1 and nur77 nuclear receptors are targets for myeloid leukemia therapy.
    Type: Application
    Filed: April 15, 2003
    Publication date: November 27, 2003
    Applicant: Baylor College of Medicine
    Inventors: Shannon E. Mullican, Orla M. Conneely, Jeffrey Milbrandt